Aspect Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
CIP
Aspect Partners's RGEN Position: Q3 2025 in Review
Aspect Partners sold out of Repligen (RGEN) in Q3 2025, closing a stake of 25 shares — an estimated $3.11K sold.
Aspect Partners first reported a position in RGEN in Q4 2023 and held it in 7 quarters. The position peaked at $71.9K in Q4 2023. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.
- Aspect Partners reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
- Aspect Partners sold 25 Repligen shares in Q3 2025, an estimated $3.11K.
- Aspect Partners first reported a position in Repligen in Q4 2023 and held it in 7 quarters.
- Aspect Partners's Repligen position peaked at $71.9K in Q4 2023.
- 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.
Based on Aspect Partners's 13F filing for Q3 2025, filed 6 Nov 2025.